GMP biologics CDMO with mammalian cell line and drug manufacturing expertise
Rezon Bio is a Poland-based contract manufacturer for mammalian biologics, operating manufacturing and development facilities under GMP. The tech stack—SAP, LIMS, HPLC, qPCR, Power BI—reflects a regulated manufacturing operation, while active projects around cell line development standardization and gene editing signal investment in automation and next-generation manufacturing capacity. Hiring is concentrated in research and senior roles, indicating focus on capability-building rather than rapid headcount expansion.
Rezon Bio is a contract development and manufacturing organization (CDMO) headquartered in Gdansk, Poland, serving pharmaceutical and biotech companies across drug substance and drug product development. The company specializes in mammalian cell line development, GMP manufacturing of biologics, and integrated biotherapeutics solutions. They operate state-of-the-art manufacturing facilities and maintain regulatory compliance across their operations. The organization combines legacy biosimilars expertise with digital transparency and cost-efficiency positioning.
Rezon Bio is a CDMO specializing in development and GMP manufacturing of mammalian biologics, including cell line development, drug substance manufacturing, and drug product development services.
Rezon Bio is headquartered in Gdansk, Poland, and currently hires in Poland across research, manufacturing, and HR functions.
Active projects include standardizing cell line development processes with automation, implementing gene editing technologies, completing CMC documentation, and launching a leadership academy program.
Other companies in the same industry, closest in size